Reconstitution experiments reveal that T cells are responsible for biofilm induction. Isogenic mutants that are no longer able to form biofilms can be used for comparison studies to determine antimicrobial resistance, especially therapeutic efficacy against P. aeruginosa located in biofilms.
Introduction
Bacteria of many species demonstrate the surprising ability to invade and colonize solid tumours. This often results in growth retardation of the neoplasm and in some cases in complete tumour clearance [1] [2] [3] [4] . This phenomenon was discovered about two centuries ago, when a French physician made the observation that tumours of patients who were also suffering from gas gangrene started to shrink. We know now that gas gangrene is caused by the bacterium Clostridium perfringens which highlights a role of bacteria in cancer therapy [5] . Later, attempts were made to intentionally infect cancer patients with bacteria [6] or treat them with bacterial components. The best known example in this context is still Coley's toxin, which comprises of a mixture of heat-killed or extracts of Streptococcus pyogenes and Serratia marcescens [7] . Although remarkable success was observed at that time [8] , the severe side effects that were encountered during treatment precluded the routine clinical use of this therapeutic strategy. Thus, the application of bacteria in cancer therapy was abandoned. Nevertheless, the Bacillus Calmette-Guérin (BCG) vaccine strain was introduced into clinical practice in the meantime as an adjuvant therapy for bladder cancer. It is highly effective in preventing relapse of this neoplasm after surgical removal [9] .
Approximately two decades ago, the idea of using bacteria as anti-cancer agents was revived [1] . This was strengthened by the accumulating knowledge of host-bacterial interactions as well as the advanced molecular genetics of many bacteria that would allow the tailoring of particular, effective bacterial strains. Such bacteria should retain their full therapeutic potential but lack the toxic properties that caused the problems in earlier clinical attempts [5, 6] . In the meantime, several bacterial species have been shown to be able to invade tumours and cause growth retardation after systemic application (Table 1) . These include facultative anaerobic bacteria, such as Salmonella enterica serovar Typhimurium (S. Typhimurium) [3, 10, 11] , S. cholerasuis [12] or Escherichia coli, as well as obligate anaerobic bacteria, such as Bifidobacterium longum [13] or Clostridium novyi [14, 15] . In addition to a direct effect, tumour-targeting bacteria might also be used as carriers for therapeutic molecules. Accordingly, Listeria monocytogenes coated with radioactively labelled antibodies showed high efficacy against metastases of pancreatic carcinoma after repeated systemic application [16] . In addition, direct injection of Salmonella into the tumour has also proved effective [17, 18] .
We, as well as others, have focused on S. Typhimurium for systemic cancer therapy [3, 10, 12, 18, 19] . Salmonella exhibit several advantages over other types of bacteria. As facultative anaerobe, Salmonella strains are able to grow in oxygenated and also in hypoxic regions of tumours [20] . The established genome sequences of several Salmonella strains [21] and the well-known biology favour their use in cancer therapy. Finally, the close relation to E. coli allows the construction of expression plasmids in laboratory E. coli strains which can be transferred to Salmonella. In addition, Salmonella are pathogens [21, 22] and we noted that certain bacterial virulence traits are required to exhibit strong therapeutic properties [23] .
An obvious question that should be addressed is: how can bacteria such as Salmonella selectively invade and colonize solid tumours after intravenous application? We observed that shortly after the systemic administration of Salmonella, there was severe haemorrhaging within the tumour. We obtained evidence to suggest that the influx of blood is due to cytokine 'expression', especially of tumour necrosis factor (TNF)-α, that is elicited when the bacteria are administered intravenously to tumour-bearing mice. Under normal circumstances, TNF-α is known to interact with blood vessel endothelium in a manner that allows blood cells and plasma proteins to reach massive infection in the tissue. In the tumour setting, with pathological angiogenesis, blood vessels are already leaky. Additional TNF-α in the circulation will particularly affect the blood vessels in the tumour. Thus, upon haemorrhae, bacteria might be flushed into the cancer tissue. Consequently we observed large necrotic regions in the tumours. Individual bacteria that have reached the tumour can extensively proliferate in these hypoxic areas because they represent immune privileged sites and provide ample nutrition through scavenging of dying cells [3] . This idea is in agreement with the type of tumour-specific Salmonella promoters that we have defined recently [24] .
The consequence of bacterial tumour colonization and the formation of a large necrotic area is the attraction of innate immune cells of the host. In particular, neutrophilic granulocytes migrate into the tumour containing bacteria and arrange themselves as a ring between the necrotic and the viable regions (Fig. 1a, 1b) . Immunohistology revealed that bacteria reside in the necrotic areas (Fig. 1a, 1b) . This was not unexpected as the bacteria can grow under hypoxic or anoxic conditions. In addition, bacteria were close to neutrophils, which are found in the quiescent zone of the tumour [25] where they form dense clusters (Fig. 1b) . To distinguish between extracellular and intracellular (i.e. phagocytosed) bacteria, electron microscopic analysis was conducted. Salmonella were found extracellularly and were surrounded by extracellular matrix which resembles that found in biofilms (Fig. 1c,d ) [26, 27] .
Biofilm formation by S. Typhimurium strain SL7207 in murine CT26 tumours
We carried out initial experiments using subcutaneously placed murine colon CT26 tumours and the Salmonella strain SL7207. This strain is generally considered to be a safe variant that can be used for human vaccination [28, 29] . It is metabolically attenuated through inactivation of the genes aroA and hisG. Thus, the bacteria are auxotrophic for aromatic amino acids and histidine. Nevertheless, the bacteria are able to survive for a considerable length of time in the wild-type (WT) murine host without harming the animals although immunocompromised mice might succumb to infections with this Salmonella strain SL7207.
This residual virulence might be advantageous for efficient colonization in tumour tissue which is essential for bacteria-mediated cancer therapy (unpublished data).
As described, the combination of bacterial colonization as well as the formation of large necrotic areas in the tumour centre led to considerable migration of neutrophilic granulocytes into the tumours (Fig. 1a) . Such cells became establihed between the necrotic areas and the viable part of the tumour [25] . Although they are highly phagocytic under normal conditions, we did not observe intracellular bacteria in tumours colonized by SL7207 (unpublished data).
This might be explained by the following reasoning: (i) hypoxia might interfere with the function of neutrophils [30] and/or (ii) bacterial defence mechanisms might obstruct phagocytosis [27] . Nevertheless, the neutrophils might interfere with the bacteria as evidenced by the fact that extensive plasmolysis can be observed in tumour-colonizing Salmonella (Fig. 1d , arrow heads). This can be considered as a sign of stress imposed on the bacteria most probably by the neutrophils [31, 32] .
The neutrophils appear to form a physical barrier resulting in the containment of bacteria within the hypoxic regions. To increase the therapeutic potential of the Salmonella strain, we aimed to remove this barrier to allow more extensive spreading of the bacteria into viable parts of the tumour [25] . Accordingly, neutrophils were depleted with antibodies. Indeed, the necrotic areas were enlarged under such circumstances and the therapeutic potency of Salmonella was also increased. It is interesting that bacterial biofilm formation was greatly reduced under such conditions as observed by electron microscopy (Fig. 1e ). This correlated with the absence of severe plasmolysis that was observed in the previous setting when neutrophils were still present [27] .
To extend these findings, we also tested Salmonella isolated from tumours of neutrophildepleted mice for expression of genes that are involved in biofilm formation. We chose to investigate the genes csgD and adrA, which directly or indirectly regulate synthesis of the biofilm constituent cellulose as well as the adhesion molecules curli and type I fimbria [33] . In contrast to bscA, which is a structural gene known to be constitutively expressed, csgD and adrA were found to be downregulated in the absence of neutrophils. Hence, as a response to host neutrophils, it is likely that the bacteria form biofilms as a defence mechanism. This could be shown independently by electron microscopy and by gene expression analysis [27] .
To evaluate this hypothesis, we deleted the genes csgD and adrA in SL7207. As expected, such variants were no longer able to form the pattern characteristic for biofilm formation on plates. In addition, the colonies displayed limited calcofluor staining (which is indicative of cellulose production). Of importance, such variants were no longer able to form biofilms in the in vivo tumour model as observed by electron microscopy. However, we observed for the first time intracellularly localized bacteria. Thus, it appears that components involved in biofilm formation that were characterized by in vitro experiments on bacterial plates, in cultures or via attachment to host cells might also be required in the in vivo situation in our tumour model. Here, the biofilms act as part of the protective system to avoid host defence mechanisms such as phagocytosis or antimicrobial peptides. The latter might also act as the trigger for the bacterial protection system as similar activities of antimicrobial peptides have been described as triggers for the two-component system (phoP/phoQ) of Salmonella [34, 35] .
In order to determine whether biofilm formation in murine solid tumours could be generally observed using Salmonella species, we tested the commonly used S. Typhimurium strains SL1344 and ATCC14028 using electron microscopy. While SL1344 showed only limited amounts of electron-dense material surrounding the bacteria indicative of weak biofilm activity of this strain in vivo, no such structures could be found using ATCC14028 (data not shown) [23] . It is known that the fimH gene encoding a cell adhesion molecule of the Salmonella strain SL1344 carries two point mutations that result in inability to adhere to host cells and block biofilm formation in vitro [23, 36] . This could explain the reduced biofilm formation by SL1344 in the tumour and suggests that additional components such as type I fimbria [19, 37] are required for biofilm formation in our in vivo model. But on the other hand, SL7207 derived from SL1344 shows strong biofilm formation in tumors.. Thus, more clarification is required to explain the difference between these two strains. Nevertheless, the inability to form biofilms does not hamper tumour colonization by these bacteria. Of note, this indicates that the genetic profile of the bacteria observed in vitro allows prediction of their in vivo behaviour in the murine tumour system and, thereby, of their general behaviour in the mammalian host [23, 27] .
In vivo biofilm formation by bacteria closely related to S. Typhimurium
Next we questioned how closely related bacterial species would behave in our in vivo biofilm system. We ourselvesfirst tested laboratory strains of E. coli such as Top10 [25] . Because these strains originated from a K12 WT strain which is known to exhibit reduced proficiency in biofilm formation [38] , it was not surprising that electron microscopic analysis showed that such bacteria were not surrounded by the extracellular matrix that had been observed for Salmonella SL7207. Similarly, probiotic WT strains of E. coli such as E. coli Nissle 1917 or Symbioflor® strains were not found to be surrounded by an extracellular polymer. Thus, under the present conditions, it is not clear whether E. coli are generally unable to form biofilms in murine solid tumours or whether we have by chance selected strains that are no longer able to do so. Of interest, despite their inability to form distinct biofilms the bacteria were never observed in an intracellular location (data not shown). Thus, these bacteria must make use of protection mechanisms against immune cells other than biofilm formation. Such mechanisms might, however, also depend on functional csgD and adrA genes.
We also tested another closely related bacterium, Shigella flexneri strain M09T (∆dap). As S.
flexneri is not a mouse pathogen, we could not apply the bacteria intravenously. Rather, the microorganisms were applied directly into the tumour. The gross appearance of the colonized tumour with regard to haemorrhage and necrosis formation was similar to that of a tumour colonized by Salmonella [25] . Again, well-organized structures were observed under these circumstances by electron microscopy. The bacterial clusters were surrounded by extracellular matrix suggesting extensive biofilm formation (Fig. 2) . The appearance of the biofilms formed by Shigella is clearly different from that of extracellular matrices formed by Salmonella. Because Shigella are very closely related to E. coli, it is reasonable to assume that E. coli in general are also capable of forming biofilms in our tumour model.
Biofilm formation by Pseudomonas aeruginosa

Clinically, one of the most important bacterial pathogens that produces biofilms is
Pseudomonas aeruginosa. This pathogen colonizes the lungs of patients with the inherited disease cystic fibrosis (CF) [39, 40] . Due to biofilm formation, the bacteria are protected from exogenous attack, for example by host defence mechanisms or the administration of antibiotics. In CF, pulmonary colonization by P. aeruginosa will eventually lead to death of the patient due to complete destruction of the lungs [41, 42] . Progress in understanding biofilm formation in the CF lung is seriously hindered by the absence of a suitable and versatile small animal model. Such a model should take into account most characteristics observed for biofilm infection in the human patient. Several animal models have been described to date; for instance, tracheal injection of P. aeruginosa embedded in agar or seaweed alginate beads in mice. In this example, matrix embedment is belived to avoid rapid bacterial clearance from the mouse lungs [43] . Similarly, a chronic bronchopulmonary infection model was proposed on the basis of a stable mucoid CF sputum isolate to overcome artificial embedding issues [43] . An alternative mammalian model of chronic otitis media infections was established in the chinchilla to evaluate bacterial persistence and biofilm formation in the middle ear [44] . However, this infection model is very inefficient and genetic manipulation is not possible in these animals. Furthermore, Drosophila melanogaster has been suggested as a potential model for studying biofilm formation in vivo [45] . This insect model suffers from the lack of an adequate immune system which might be important for the induction of biofilm formation by P. aeruginosa. Thus, none of the small animal models reported to date offers the versatility that is currently required for investigations of the physiology and development of in vivo biofilms as well as the bacterial factors involved. We therefore sought to determine whether the murine CT26 solid tumour model, which has already been successfully employed to investigate biofilm formation by S. Typhimurium, could be used in this situation.
When P. aeruginosa was adminsteredintravenously to CT26-bearing mice, the tumours were colonized with kinetics similar to those observed for Salmonella. Haemorrhage of the tumour was observed shortly after bacterial administration and a large necrotic area was subsequently formed. Although the bacteria are not truly anaerobic, individual bacteria could be detected in the necrotic areas which are most likely to be completely anoxic. As observed previously, the bacteria and probably also the necrotic tissue attracted a substantial number of neutrophils that accumulated between the viable and the necrotic part of the tumour [3, 46] . It is interesting that the bacteria were located on both sides of the neutrophil accumulation and intermingled with these cells. Thus, for as yet unknown reasons and in contrast to Salmonella, this bacterial species was found in viable parts of the tumour [25, 27] .
Histology revealed that the WT bacteria formed dense clusters that would be a precondition for biofilm formation (Fig. 3a) . Indeed, there is electron microscopic evidence that biofilms are formed by P. aeruginosa (Fig. 3a) , and the bacteria are surrounded by extracellular matrix. It is noteworthy that cluster and biofilm formation was dependent on an intact quorum-sensing system. P. aeruginosa carries two independent quorum-sensing systems using N-acylhomoserine lactone and 4-quinolones as ligands. Therefore we tested an isogenic mutant of PA14 carrying a defect in pqsA, a structural gene involved in the synthesis of 4-quinolone. Although able to colonize tumours in the same manner as WT bacteria, the pqsA mutant was unable to form clusters and biofilm-like structures as observed by electron microscopy (Fig. 3) . Similar data were obtained using a variant that was defective in the pel system which is essential for forming the polycarbonate extracellular matrix (unpublished data).
Next we addressed whether biofilm formation by P. aeruginosa is also a bacterial defence reaction against the immune system of the host, as shown for Salmonella. Therefore, we depleted neutrophils as described previously [27] . All neutrophil-depleted mice died shortly after infection with WT strain PA14. Similar observations were made following complement depletion. Thus, mechanisms of innate immune defence are apparently more important for the mice to survive P. aeruginosa infections than Salmonella infections. Nevertheless, we obtained evidence that biofilm formation by P. aeruginosa in murine tumours is also a protective response against the immune system of the host. When similar experiments were carried out in Rag1 -/-mice that lack the adaptive immune system, i.e. T and B cells, bacteria no longer formed biofilms. However this ability was regained after the mice had been reconstituted with splenic cells from normal mice or mice lacking B cells but containing T cells [45] . Therefore we do not believe that T cells directly influence the bacteria as at present no efficient harmful effector T cell mechanism is known. Instead we propose that T cells activate myeloid cells such as macrophages or neutrophils which then act on the bacteria to elicit biofilm formation for protection [46] . However the details of this hypothesis require further investigation.
The availability of isogenic bacterial strains capable of colonizing tumours to a similar degree, but selectively able or unable to form biofilms, provides the possibility to screen the efficiency of antibiotics for treatment of P. aeruginosa infections. Among others, we tested ciprofloxacin -an antibiotic that is commonly used in clinical practice -which is also used to treat Pseudomonas in CF patients. A clear distinct phenotype was observed between bacteria able and unable to form biofilms (Fig. 3b) . Whereas the biofilm-forming bacteria were resistant to a single dose of antibiotics, the variants that were unable to form biofilms showed significant sensitivity to treatment. By contrast, when localized in organs outside the tumour (e.g. liver), bacteria were equally sensitive, as they are unable to form biofilms in these tissues. Thus, the murine tumour model of biofilm formation by P. aeruginosa has great potential as a system in which (i) physiological parameters involved in triggering biofilm formation by these bacteria can be determined, (ii) co-infection experiments can be conducted with bacteria that are known to simultaneously colonize the CF lung and, most importantly, (iii) the activity of (new) antibiotics can be dissected as a prerequisite for the development of novel anti-infective agents able to act against biofilm-forming P. aeruginosa [46] . Typhimurium. At present, our main aim is to attenuate S. Typhimurium in order to generate bacterial strains that will be suitable for treatment of patients. Nevertheless, with regard to clinical applications, there is still speculation that attenuated safe strains might be therapeutically inferior to virulent strains. Therefore, it may be a considerable time before the systemic application of therapeutic bacteria becomes a reality. aeruginosa, this system provides great promise for understanding and treating biofilms in patients.
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